Top 10 Companies in the Global Biological Chip Market (2026): Market Leaders Driving Innovation

MARKET INSIGHTS

Global biological chip market was valued at USD 1,380 million in 2024 and is projected to reach USD 2,870 million by 2032, growing at a CAGR of 9.60% during the forecast period (2025‑2032). Biological chips are miniaturized devices that allow thousands of biological reactions to be performed simultaneously, enabling high‑throughput analysis of biological molecules.

These chips are primarily categorized into DNA chips, lab‑on‑a‑chip, protein chips, and others. DNA chips dominate the market due to their widespread use in genomics research and diagnostics. Lab‑on‑a‑chip technology is gaining traction for its ability to integrate multiple laboratory functions on a single chip, while protein chips are increasingly used in proteomics research and drug discovery.

Key market drivers include the growing demand for personalized medicine, increasing investments in life sciences research, and technological advancements in microfluidics. The pharmaceutical and biotechnology sector accounts for the largest share of biological chip applications, followed by diagnostic centers and academic research institutions. North America currently leads the market, with significant contributions from the U.S. biotechnology sector, while Asia‑Pacific is expected to witness the fastest growth due to expanding healthcare infrastructure and research capabilities.

Global Biological Chip Market – View in Detailed Research Report

10️⃣ 1. Illumina, Inc.

Headquarters: San Diego, California, USA
Key Offering: DNA sequencing platforms and high‑density microarray systems

Illumina’s portfolio of next‑generation sequencing and array solutions positions it as a central driver of genomic data generation. The company’s focus on expanding single‑cell analysis capabilities has broadened its market footprint across research and clinical settings.

Sustainability & Growth Initiatives:

• Investment in low‑energy consumable consumables for sequencing workflows

• Partnerships with academic institutions to accelerate biomarker discovery

• Expansion of global service centers to support rapid turnaround for clinical labs

9️⃣ 2. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Integrated bio‑analysis systems, including microfluidic chips and automated sample processors

Thermo Fisher’s extensive distribution network and broad product line allow it to serve both large‑scale research facilities and smaller diagnostic labs. Its recent investment in Asia‑Pacific capacity underscores a strategic focus on emerging markets.

Sustainability & Growth Initiatives:

• Launch of a circular supply chain program for consumables

• Collaboration with public‑health agencies to deploy rapid testing platforms

• Expansion of AI‑driven data interpretation services for clinical use

8️⃣ 3. Agilent Technologies, Inc.

Headquarters: Santa Clara, California, USA
Key Offering: Lab‑on‑a‑chip solutions and advanced analytical instrumentation

Agilent’s microfluidic platforms enable rapid, multiplexed assays that are particularly valuable in drug discovery and precision diagnostics. The company’s focus on precision instrumentation aligns with the growing demand for high‑accuracy data.

Sustainability & Growth Initiatives:

• Development of low‑power chip architectures for field deployment

• Strategic alliances with biotech startups to co‑create next‑generation platforms

• Investment in training programs for bio‑informatics professionals

7️⃣ 4. Roche Diagnostics

Headquarters: Basel, Switzerland
Key Offering: Protein chip arrays and multiplex immunoassays

Roche’s protein chip technology supports high‑throughput proteomics and biomarker validation, serving both academic research and pharmaceutical development pipelines.

Sustainability & Growth Initiatives:

• Partnerships with global health organizations to expand diagnostic access

• Implementation of eco‑friendly manufacturing processes for consumables

• Expansion of cloud‑based data analytics services for clinicians

6️⃣ 5. Bio‑Rad Laboratories, Inc.

Headquarters: Hercules, California, USA
Key Offering: Protein chip systems and microarray solutions

Bio‑Rad’s focus on protein chip innovation provides researchers with tools for large‑scale proteomic profiling, supporting drug target validation and biomarker discovery.

Sustainability & Growth Initiatives:

• Development of modular chip designs to reduce waste

• Collaborations with universities to drive next‑generation platform research

• Enhancement of user‑friendly software for data analysis

5️⃣ 6. Fluidigm Corporation

Headquarters: San Francisco, California, USA
Key Offering: Microfluidic chip solutions for single‑cell and multiplex assays

Fluidigm’s microfluidic platforms enable precise control of sample volumes, making them ideal for high‑resolution single‑cell studies and complex assay designs.

Sustainability & Growth Initiatives:

• Investment in low‑power chip fabrication techniques

• Strategic partnerships with pharma to accelerate drug discovery workflows

• Expansion of educational resources for bio‑informatics training

4️⃣ 7. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA
Key Offering: Diagnostic platforms incorporating chip‑based assays for infectious disease detection

Abbott’s integration of chip technology into point‑of‑care diagnostics enhances test speed and accuracy, supporting rapid clinical decision‑making.

Sustainability & Growth Initiatives:

• Development of portable testing kits for field deployment

• Collaborations with global health NGOs to expand diagnostic reach

• Commitment to reducing carbon footprint of manufacturing operations

3️⃣ 8. PerkinElmer, Inc.

Headquarters: Boston, Massachusetts, USA
Key Offering: Bio‑analysis solutions including microarray and lab‑on‑a‑chip instruments

PerkinElmer’s broad product portfolio supports diverse research needs, from basic science to clinical diagnostics.

Sustainability & Growth Initiatives:

• Investment in green chemistry for consumable production

• Strategic alliances with biotech firms to co‑develop advanced platforms

• Expansion of data‑science support services for customers

2️⃣ 9. EMD Millipore

Headquarters: Burlington, Massachusetts, USA
Key Offering: Chromatography and microarray systems for analytical laboratories

EMD Millipore’s integration of chip‑based analysis with traditional chromatography enhances throughput and resolution for complex sample sets.

Sustainability & Growth Initiatives:

• Development of reusable chip modules to reduce consumable waste

• Collaboration with academia to validate new assay formats

• Commitment to ISO 14001 environmental management standards

1️⃣ 10. SuperBioChips Laboratories

Headquarters: Seoul, South Korea
Key Offering: High‑density DNA arrays and custom chip design services

SuperBioChips focuses on providing tailored chip solutions for genomics and agricultural research, positioning itself at the intersection of biomedicine and ag‑bio.

Sustainability & Growth Initiatives:

• Investment in low‑cost fabrication processes for large‑scale production

• Partnerships with Korean research institutes to accelerate platform validation

• Support for open‑source bio‑informatics tool development

Global Biological Chip Market – View in Detailed Research Report

Global Biological Chip Market – View in Detailed Research Report

🌍 Outlook: The Future of Biological Chip Market

The trajectory of the biological chip market is shaped by the convergence of high‑throughput analytics, AI‑driven data interpretation, and the expanding demand for point‑of‑care testing. As diagnostic and research institutions seek faster, more accurate results, the adoption of chip‑based platforms is expected to accelerate across both clinical and research settings.

📈 Key Trends Shaping the Market

• Miniaturization of lab‑on‑a‑chip devices for decentralized testing

• Integration of machine‑learning algorithms to streamline biomarker discovery

• Expansion of chip platforms into agricultural biotechnology for crop improvement

• Strategic collaborations between chip manufacturers and pharma to support early‑phase drug discovery

• Growth of cloud‑based analytics services that democratise access to complex data processing

🔮 Future Trends

Emerging developments point to a future where biological chips become integral to personalized medicine, real‑time monitoring, and global health surveillance. Continued investment in microfluidics, coupled with advances in AI and cloud infrastructure, will lower barriers to entry and broaden the range of applications, from infectious disease diagnostics to precision agriculture.